Celltrion gears up for subcutaneous infliximab launch in EuropeCelltrion Healthcare’s subcutaneous (SC) formulation of its infliximab biosimilar, codenamed CT-P13 SC, looks set to launch in Europe Share XCelltrion gears up for subcutaneous infliximab launch in Europehttps://pharmaphorum.com/views-analysis-market-access/celltrion-gears-up-for-subcutaneous-infliximab-launch-in-europe/
